Skip to main content

Table 3 Multinomial Logistic Analysis for the Multistage Development of Esophageal Carcinoma

From: Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma

 

Unadjusted OR & 95%CL

Adjusted OR & 95%CL*

variables

ESSC

dysplasia

Basal cell hyperplasia

ESSC

dysplasia

Basal cell hyperplasia

ADP

1.02(0.98-1.06)

1.03(0.99-1.07)

1.01(0.97-1.05)

1.02(0.97-1.06)

1.03(0.99-1.07)

1.01(0.96-1.05)

oxLDL

0.92(0.88-0.94)

0.98(0.94-1.01)

0.96(0.92-1.00)

0.94(0.89-0.99)

0.97(0.93-1.01)

0.95(0.91-0.99)

oxLDL-ab

0.93(0.88-0.97)

0.98(0.96-1.01)

1.00(0.98-1.02)

0.96(0.91-1.00)

0.98(0.95-1.01)

1.00(0.98-1.02)

oxLDL-lgG

0.94(0.87-1.01)

1.07(1.01-1.14)

1.09(1.03-1.16)

1.03(0.94-1.13)

1.07(0.99-1.16)

1.07(0.99-1.15)

oxLDL-lgM

1.21(1.10-1.33)

1.15(1.05-1.27)

1.11(1.01-1.22)

1.18(1.06-1.31)

1.11(1.01-1.23)

1.08(0.98-1.20)

  1. Abbreviations: TC, total cholesterol; TG, triglyceride; ADP, adiponectin; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; oxLDL, oxidized low-density lipoprotein; oxLDL-lgG, immunoglobulin G type of autoantibodies to oxidized low-density lipoprotein; oxLDL-lgM, immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein.
  2. *:adjusted for age, albumin, TC, HDL, and LDL.